Norway's Fledgling Precision Oncology Effort Finding Early Success
The program includes a new national infrastructure for diagnostics and a clinical trial, which have identified targeted treatments for dozens of patients.
Novartis Incyte Eli Lilly Foundation Medicine Oslo University Hospital Kjetil Task National Tumor Board National Molecular Tumor Board
Source: precisiononcologynews.com